The signal transduction and drug development of epithelial-mesenchymal transition

Chinese Pharmacological Bulletin

Volumn 24, Issue 9, 2008, Pages 1131-1134

  Xu, Si Yun ^a   Li, Jing ^a   Geng, Mei Yu ^a  

^a OCEAN UNIVERSITY OF CHINA   (China)

Author keywords

Epithelial cell; Epithelial mesenchymal transition; Mesenchymal cell; Signaling transduction; Tumor metastasis

Indexed keywords

BETA CATENIN; CETUXIMAB; CYCLIN D1; CYCLOPAMINE; DISHEVELLED PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; FRIZZLED PROTEIN; GEFITINIB; GLYCOGEN SYNTHASE KINASE 3BETA; HISTONE DEACETYLASE; HISTONE H3; HISTONE H4; JAGGED1; MITOGEN ACTIVATED PROTEIN KINASE; MYC PROTEIN; NOTCH RECEPTOR; NVP AEW 541; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P53; RAS PROTEIN; SONIC HEDGEHOG PROTEIN; STRESS ACTIVATED PROTEIN KINASE; SULINDAC; T CELL FACTOR PROTEIN; TRANSCRIPTION FACTOR ELK 1; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; UNINDEXED DRUG; WNT PROTEIN;

ARTICLE; DRUG RESEARCH; EMBRYO DEVELOPMENT; EPITHELIUM CELL; HUMAN; MESENCHYME CELL; METASTASIS; SIGNAL TRANSDUCTION;

EID: 58149095303     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Yao C, Lai M D. EMT and its molecular mechanism[J]. Int J Genet, 2006, 29 (4):290-4.
2. Huber M A, Kraut N, Beug H. Molecular req uirement for epithelial- mesenchymal transition during tumor progression[J]. Cell Biology, 2005, 17:548-58.
3. Lee J M, Dedhar S, Kalluri R, Erik W. Thompson. The epithelial-mesenchymal transition: new insights in signaling, development, and disease[J]. J Cell Biol, 2006, 172 (7):973-81.
4. Thuault S, Valcourt V, Petersen M, et al. Transforming growth factor-β employs HMGA2 to elicit epithelial-mesenchymal transition [J]. J Cell Biol, 2006, 174 (2):175-83.
5. David I, Bellovin, Richard C, et al. Altered Localization of p120 catenin during epithelial to mesenchymal transition of colon carcinoma is prognostic for aggressive disease[J]. Cancer Res, 2005, 65 (23):10938-45.
6. Yook J I, Li X Y, Ota I, et al. Wnt-dependent regulation of the e-cadherin repressor snail[J]. J Biol Chem, 2005, 280 (12):11740-8.
7. Rosivatz E, Beeker I, Specht K, et al. Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1 and twist in gastric cancer[J]. Am J Pathol, 2002, 161 (5):1881-91.
8. Behrens J. The role of the Wnt signalling pathway in colorectal tumorigenesis [J]. Biochemical Society Transactions, 2005, 33:672-5.
9. Behrens J, Lusting B. The Wnt connection to tumorigenesis [J]. Int J Dev Biol, 2004, 48 (5-6):477-87.
10. Zhang W, Liu S, Xu N Z. Wnt and its role in tumorigenesis [J]. World Chin J Digestol, 2002, 10:1201-5.
11. Timmerman L A, Grego-Bessa J, Raya A, et al. Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation[J]. Genes & Dev, 2004, 18:99-115.
12. Grego-Bessa J, Diez J, Timnerman L, de la Pompa J L. Notch and Epithelial -Mesenchymal Transition in Develop-ment and Tumor Progression: another turn of the screw[J]. Cell Cycle June. 2004, 3 (6):718-21.
13. Sun L. Notch and cancer[J]. Foreign Med Sci Oncol sect, 2004, 31 (9):655-8.
14. Feng Y H, Zhu Y F, Sun W J. Hedghog and tumorigenesis [J]. Cancer Prevent Cure Res, 2005, 32 (12):796-9.
15. Guo J F, Gao J, Li Z S. Role of Hedgehog-GLI signaling pathway in the tumorigenesis of pancreatic cancer[J]. World Chin J Digestol, 2007, 15 (10):1137-40.
16. Galliher A J, Schiemann W P. β3 Integrin and Src facilitate transforming growth factor-β mediated induction of epithelial-mesenchymal transition in mammary epithelial cells[J]. Breast Cancer Res, 2006, 8 (4):R42.
17. Bolós V, Peinado H, Pérez-Moreno M A, et al. The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors [J]. J Cell Sci, 2002, 116 (3):499-511.
18. 1 cooperating with transcriptional factor Snail promotes breast tumor metastasis[J]. Chin Pharmacol Bull, 2007, 23 (10):1317-21.
19. Vandewalle C, Comijn J, De Craene B, et al. SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions [J]. Nucleic Acids Research, 2005, 33 (20):6566-78.
20. Li L, Zhu Q, Lu Y. Cell adhesion molecules and metastasis[J]. Chin Pharmacol Bull, 2007, 23 (5):568-71.
21. Moustakas A, Heldin C H. Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression [J]. Cancer Science, 2007, 98 (10):1512-20.
22. Vaidés F, Alvarez A M, Locascio A, et al. The epithelial mesenchymal transition confers resistance to the apoptotic effects of transforming growth factor β in fetal rat hepatocytes [J]. Mol Cancer Res, 2002, 1:68-78.
23. Mimeault M, Jouy N, Depreux P, et al. Synergistic antiproliferative and apoptotic effects induced by mixed epidermal growth factor receptor inhibitor ZD1839 and nitric oxide donor in human prostatic cancer cell lines[J]. Prostate, 2005;62:187-99.
24. Neiva K, Sun Y X, Taichman R S. The role of osteoblasts in regulating hematopoietic stem cell activity and tumor metastasis [J]. Braz J Med Biol Res, 2005, 38:1449-54.
25. Larsson O. Role of insulin-like growth factor/receptor signaling in cancer[J]. Br JC, 2005, 92:2097-101.
26. Samani A A. The role of the IGF system in cancer growth and metastasis: overview and recent insights [J]. Endocr Rev, 2007, 28 (1):20-47.
27. Yang S, Lu H S. Progress of research on the relationship between Writ signal transduction and digestive tract tumors[J]. World Chin J Digestol, 2007, 15 (27):2880-4.
28. Mimeault M, Batra S K. Recent advances on multiple tumorigenic cascades involved in prostatic cancer progression and targeting therapies[J]. Carcinogenesis, 2006;27:1-22.
29. Wicha M S, Liu S, Dontu G. Cancer stem cells: an old idea-a paradigm shift[J]. Cancer Res, 2006, 66:1883-90.
30. Mimeault M , Batra S K. Interplay of distinct growth factors during epithelial-mesenchymal transition of cancer progenitor cells and molecular targeting as novel cancer therapies[J]. Annals Oncol, 2007, 18 (10):1605-19.
31. Mimeault M, Moore E, Moniaux N, et al. Cytotoxic effects induced by a combination of cyclopamine and gefitinib, the selective hedge-hog and epidermal growth factor receptor signaling inhibitors, in prostate cancer cells[J]. Int J Cancer, 2006, 118:1022-31.
32. Jechlinger M, Sommer A, Moriggl R, et al. Autocrine PDGFR signaling promotes mammary cancer metastasis[J]. J Clin Invest, 2006, 116 (6):1561-70.
33. Grände M, Franzen A, Karlsson J Q, et al. Transforming growth factor-β and epidermal growth factor synergistically stimulate epithelial to mesenchymal transition (EMT) through a MEK dependent mechanism in primary cultured pig thyrocytes[J]. J Cell Sci, 2002, 115 (22):4227-36.
34. Huang J E, Wang H J, Liu H G, et al. Protective effects of aFGF on gentamicin-induced injuries of rat's renal tubular epithelial cells in vitro[J]. Chin Pharmacol Bull, 2007, 23 (11):1455-7.